1/2

Export Ready

Cefepime Hydrochloride & Tazobactam Sodium for Injection 281.25mg

Name: Cefepime Hydrochloride & Tazobactam Sodium for Injection 281.25mg
SKU: 8416300
Availability: InStoreOnly

Sold by r k lifecare inc · Manufacturer, Retailer, Distributor, Wholesaler · Mumbai, Maharashtra, India

Price

Price on request

In stock

Inclusive of all taxes

Minimum order: 1 Centimetre

Export Snapshot

MOQ

1 Centimetre

Lead time

On request

Packaging

Vial containing 281.25 mg dry powder

Shelf life / longevity

As per product specification

HS Code

On request

Origin

India

Port of dispatch

On request

Export markets served

Global markets

Values shown are for r k lifecare inc.

Compliance & Certifications

Suitable for

Importers · Distributors · Wholesalers

Mumbai Dispatch on request Verified seller

r k lifecare inc

Manufacturer, Retailer, Distributor, Wholesaler · Mumbai, Maharashtra, India

Registered address: Haryana, India.

View profile All products

Established

Not shared

Employees

–

GST

NOT SHARED

IEC code

Not shared

Export markets

Global markets

GlobalLinker Member Since

Not shared

Turnover

Incorporation Type

On request

Verified Seller

Product details

What are the specifications of this product?

Overview

Cefepime Hydrochloride & Tazobactam Sodium for Injection 281.25 mg is a combination antibiotic that includes a fourth-generation cephalosporin with a beta-lactamase inhibitor, extending the efficacy of the drug against resistant bacteria. Here's an overview:

Product Description

Key Features:

Form: Dry powder for injection.

Strength: 281.25 mg (combined dosage of Cefepime Hydrochloride and Tazobactam Sodium).

Cefepime: Typically 250 mg

Tazobactam: Typically 31.25 mg

Description provided by r k lifecare inc.

Specifications

Active Ingredients	Cefepime Hydrochloride 250 mg + Tazobactam Sodium 31.25 mg
Formulation Type	Dry powder for injection
Route of Administration	Intravenous (IV) or Intramuscular (IM)
Reconstitution	Requires reconstitution with sterile water or recommended diluent prior to administration
Packaging	Vial containing 281.25 mg dry powder
Storage Conditions	Store below 25°C, protect from moisture and light
Shelf Life	Typically 24 months from manufacture date
Manufacturer Compliance	Manufactured under GMP with stringent quality controls
Pharmacological Class	Fourth-generation cephalosporin and beta-lactamase inhibitor combination
Common Indications	Nosocomial infections, severe bacterial infections, and resistant bacterial infections

Use cases

Category	Pharmaceuticals > Antibiotics > Injectable Antibiotics
Primary application	Wholesale, distribution, and international sourcing
Brand	Not specified
Product type	Product

Logistics & handling

Lead time	On request
Packaging	Vial containing 281.25 mg dry powder
Storage condition	As recommended by supplier
Origin	India
Form	As listed by supplier

Commercials (this seller)

Minimum order	1 Centimetre
Lead time	On request
Payment terms	As per negotiated commercial agreement.
Checkout type	enquiry

Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing Cefepime Hydrochloride & Tazobactam Sodium for Injection 281.25mg. Answers compiled from verified sellers' commercial terms and platform data.

Q: What is the advantage of combining Cefepime Hydrochloride with Tazobactam Sodium in this injection?

A: The combination enhances the antibiotic spectrum by protecting Cefepime from beta-lactamase enzyme degradation through Tazobactam's inhibitory action, making the drug effective against beta-lactamase producing resistant bacteria.

Q: What infections is Cefepime Hydrochloride & Tazobactam Sodium injection specifically indicated for?

A: It is indicated for complicated urinary tract infections, pneumonia, skin and soft tissue infections, and intra-abdominal infections, especially those caused by resistant bacterial strains.

Q: How should the Cefepime Hydrochloride & Tazobactam Sodium 281.25 mg powder be prepared for administration?

A: The sterile dry powder must be reconstituted with sterile water or a recommended diluent as per clinical guidelines before intravenous or intramuscular injection.

Q: Can this injection be used to treat hospital-acquired infections?

A: Yes, due to its broad-spectrum activity and enhanced resistance profile, it is highly effective against hospital-acquired infections caused by resistant organisms.

Q: What storage conditions are recommended for this injection formulation?

A: The product should be stored below 25°C in a dry place, protected from moisture and light to maintain its potency and sterility.

Question not answered? Ask sellers directly — typical response within 4 hours.